おかえりなさい
アカウント登録
siteでログインする
siteで登録する
受信トレイを確認する
China Orient Asset Management (International) Holding
About
COAMCI is one of the group’s primary overseas platform focusing on investment & asset management.
- Central,Hong Kong Island,Hong Kong
- https://www.coamci.com
Highlights
Details
- Industries
- Asset Management,Finance,Financial Services
- Founded date
- Oct 27, 1999
- Operating Status
- Active
- Legal Name
- China Orient Asset Management (International) Holding Limited
- Also Known As
- COAMCI,中国东方资产管理（国际）控股有限公司
- Investor Type
- PE
Headquartered in Hong Kong, China Orient Asset Management (International) Holding Limited (COAMCI), a wholly-owned subsidiary of China Orient Asset Management Co., Ltd. (COAMC), which founded in 2002 and subsequently restructured and renamed in June 2011.COAMCI is one of the Group’s primary overseas platform focusing on investment, asset management etc, as a bridge between domestic resources and overseas markets, delivering a specialized, diversified and comprehensive range of financial services solution. Fully utilizing the company’s multi-market and multi-currency capabilities to its advantage. With the deep understanding of the Chinese market and the benefit of investment acumen in global markets, COAMCI has kept steady growth in asset value.
Investments
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Dec 30, 2019
Jiumaojiu
|
Series Unknown | $55M | Food and Beverage | — |
|
Jan 12, 2018
Suzhou Kintor Pharmaceuticals
|
Series C | $44M | Biopharma | — |
|
May 12, 2017
Yixin Capital
|
Private Equity（PE） | ¥4B | Auto Insurance | — |
|
Mar 21, 2017
Angiotech Pharmaceuticals
|
Series Unknown | — | Health Care | — |
|
Nov 8, 2000
FreeBorders
|
Series B | $25M | Consulting | — |
Employee Profiles
Exits
China Orient Asset Management (International) Holding has had 3 exits. China Orient Asset Management (International) Holding most notable exits include Jiumaojiu , Angiotech Pharmaceuticals
| Date | Company Name | Exit Type | Industry | |
|---|---|---|---|---|
| Jan 15, 2020 | Jiumaojiu | IPO | Food and Beverage | Detail |
| Dec 19, 2016 | Angiotech Pharmaceuticals | M&A | Health Care | Detail |
| Oct 1, 2013 | FreeBorders | M&A | Consulting | Detail |
